Gastroenterology
Volume 129, Issue 3 , Pages 797-806 , September 2005

Natural Variation in Toxicity of Wheat: Potential for Selection of Nontoxic Varieties for Celiac Disease Patients

  • Liesbeth Spaenij–Dekking

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • Corresponding Author InformationAddress requests for reprints to: Liesbeth H. A. Spaenij-Dekking, Department of Immunohematology and Blood Transfusion, E3-Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Yvonne Kooy–Winkelaar

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • Peter van Veelen

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • Center for Medical Systems Biology, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • Jan Wouter Drijfhout

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • Harry Jonker

      Affiliations

    • Plant Research International, Wageningen, The Netherlands
  • ,
  • Loek van Soest

      Affiliations

    • Centre for Genetic Resources, Wageningen, The Netherlands
  • ,
  • Marinus J.M. Smulders

      Affiliations

    • Plant Research International, Wageningen, The Netherlands
    • Allergy Consortium, Wageningen, The Netherlands
  • ,
  • Dirk Bosch

      Affiliations

    • Plant Research International, Wageningen, The Netherlands
  • ,
  • Luud J.W.J. Gilissen

      Affiliations

    • Plant Research International, Wageningen, The Netherlands
    • Allergy Consortium, Wageningen, The Netherlands
  • ,
  • Frits Koning

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

Received 7 October 2004 ,Accepted 26 May 2005.

References 

  1. Anderson RP , Degano P , Godkin AJ , Jewell DP , Hill AV . In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope . Nat Med . 2000;6:337–342
  2. Fleckenstein B, Molberg O, Qiao SW, Schmid DG, Von Der MF, Elgstoen K, et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease . J Biol Chem . 2002;277:34109–34116
  3. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease . Nat Med . 1998;4:713–717
  4. Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, et al. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase . Eur J Immunol . 2001;31:1317–1323
  5. Quarsten H , Molberg O , Fugger L , McAdam SN , Sollid LM . HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope . Eur J Immunol . 1999;29:2506–2514
  6. Sjostrom H, Lundin KE, Molberg O, Korner R, McAdam SN, Anthonsen D, et al. Identification of a gliadin T-cell epitope in coeliac disease (general importance of gliadin deamidation for intestinal T-cell recognition) . Scand J Immunol . 1998;48:111–115
  7. Vader LW, De Ru A, van der WY, Kooy YM, Benckhuijsen W, Mearin ML, et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease . J Exp Med . 2002;195:643–649
  8. van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity . J Immunol . 1998;161:1585–1588
  9. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, et al. Gliadin-specific, HLA-DQ (alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients . J Exp Med . 1993;178:187–196
  10. van de Wal Y, Kooy YM, van Veelen PA, Pena SA, Mearin LM, Molberg O, et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin . Proc Natl Acad Sci U S A . 1998;95:10050–10054
  11. Nilsen EM , Lundin KE , Krajci P , Scott H , Sollid LM , Brandtzaeg P . Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma . Gut . 1995;37:766–776
  12. Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease . Gastroenterology . 1998;115:551–563
  13. Przemioslo RT , Lundin KE , Sollid LM , Nelufer J , Ciclitira PJ . Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody . Gut . 1995;36:874–879
  14. Shewry PR , Halford NG . Cereal seed storage proteins (structures, properties and role in grain utilization) . J Exp Botany . 2002;53:947–958
  15. Paulsen G , Lundin KE , Gjertsen HA , Hansen T , Sollid LM , Thorsby E . HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201 . Hum Immunol . 1995;42:145–153
  16. Vader W, Kooy Y, van Veelen P, De Ru A, Harris D, Benckhuijsen W, et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides . Gastroenterology . 2002;122:1729–1737
  17. van de Wal Y, Kooy YM, van Veelen P, Vader W, August SA, Drijfhout JW, et al. Glutenin is involved in the gluten-driven mucosal T cell response . Eur J Immunol . 1999;29:3133–3139
  18. Molberg O, Solheim FN, Jensen T, Lundin KE, Arentz-Hansen H, Anderson OD, et al. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease . Gastroenterology . 2003;125:337–344
  19. Marti T , Molberg O , Li Q , Gray GM , Khosla C , Sollid LM . Prolyl endopeptidase mediated destruction of t cell epitopes in whole gluten—chemical and immunological characterization . J Pharmacol Exp Ther . 2005;312:19–26
  20. Piper JL , Gray GM , Khosla C . Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo . J Pharmacol Exp Ther . 2004;311:213–219
  21. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, et al. Structural basis for gluten intolerance in celiac sprue . Science . 2002;297:2275–2279
  22. Anderson OD , Litts JC , Greene FC . The alpha-gliadin gene family. I. Characterization of ten new wheat alpha-gliadin genomic clones, evidence for limited sequence conservation for flanking DNA, and southern analysis of the gene family . Theor Appl Genet . 1997;95:50–58
  23. Vader LW, Stepniak DT, Bunnik EM, Kooy YM, de Haan W, Drijfhout JW, et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains . Gastroenterology . 2003;125:1105–1113
  24. Spaenij-Dekking EH , Kooy-Winkelaar EM , Nieuwenhuizen WF , Drijfhout JW , Koning F . A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin . Gut . 2004;53:1267–1273
  25. van Eckert R . In: The PWG gliadin, a new reference material . 2000;p. 25–27 Proceedings of the 16th meeting Working Group on Prolamin Analysis and Toxicity. Sitges, Spain
  26. Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, Kooy YM, et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase . J Exp Med . 2000;191:603–612
  27. Ivarsson A, Persson LA, Nystrom L, Ascher H, Cavell B, Danielsson L, et al. Epidemic of coeliac disease in Swedish children . Acta Paediatr . 2000;89:165–171
  28. Mearin ML, Biemond I, Pena AS, Polanco I, Vazquez C, Schreuder GT, et al. HLA-DR phenotypes in Spanish coeliac children (their contribution to the understanding of the genetics of the disease) . Gut . 1983;24:532–537
  29. Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses . Proc Natl Acad Sci U S A . 2003;100:12390–12395
  30. van Overbeek FM , Uil-Dieterman IG , Mol IW , Kohler-Brands L , Heymans HS , Mulder CJ . The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population . Eur J Gastroenterol Hepatol . 1997;9:1097–1099
  31. Molberg O, Uhlen AK, Jensen T, Solheim Flaete N, Fleckenstein B, Arentz-Hansen H, et al. Mapping of gluten T-cell epitopes in bread wheat ancestors (implications for celiac disease) . Gastroenterology . 2005;128:393–401

 Supported by the Celiac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK03009), the Stimuleringsfonds Voedingsonderzoek Leiden University Medical Center, by grants from the European Community (QLRT-2000-00657 and QLRT-2002-02077), and by the Center for Medical Systems Biology, a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.

PII: S0016-5085(05)01119-4

doi: 10.1053/j.gastro.2005.06.017

Gastroenterology
Volume 129, Issue 3 , Pages 797-806 , September 2005